Noninvasive Determination of Cerebral Tissue Oxygenation in Pulmonary Hypertension
Pulmonary Hypertension
About this trial
This is an interventional diagnostic trial for Pulmonary Hypertension focused on measuring Pulmonary Hypertension,, NIRS,, Near-infrared spectroscopy,, cerebral tissue oxygenation,, cerebral blood flow
Eligibility Criteria
Inclusion criteria: Inclusion criteria are age 18 years or older, to be scheduled for RHC due to suspected or known PH and the ability to give informed consent. Both genders will be accepted.
Exclusion criteria: Exclusion criteria are: inability to follow the study due to language or cognitive problems (e.g. a major active psychiatric disorders, prior traumatic brain injury, and neurologic disease), dementia on the basis of a Mini Mental State Test and pregnant women.
Sites / Locations
- University Hospital Zurich, Pneumology
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm 4
Experimental
Experimental
Experimental
Experimental
AIR
NO
Oxygen
Target Oxygen
Randomization sequences according to modified catheter protocol. 1. AIR 2. Target Oxygen(88-90%) 3. 100% Oxygen 4. Nitric Oxygen
Randomization sequences according to modified catheter protocol. 1.Nitric Oxygen 2. AIR 3. Target Oxygen(88-90%) 4. 100% Oxygen
Randomization sequences according to modified catheter protocol. 1. 100% Oxygen 2. NO 3. AIR 4. Target Oxygen (88-90%)
Randomization sequences according to modified catheter protocol. 1. Target Oxygen (88-90%) 2. 100% Oxygen 3. NO 4. AIR